Type 2 diabetes drug Mounjaro and weight-loss drug Zepbound remained the brightest stars in Lilly's lineup. Mounjaro's sales more than doubled year over year to $3.1 billion. Sales for Zepbound, which ...

Big Brother fans have been left divided by an awkward row between Sarah and Khaled. Monday's (November 4) episode saw the ...

The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the fourth quarter of 2024 of $1.30 ...

Lily Collins rocked a blonde, pigtail wig for her Halloween 2024 costume as Baby Spice. The Emily in Paris star also donned a ...

Eli Lilly’s Alzheimer’s disease offering Kinsunla is poised to face a tough road ahead in the U.K. While the region’s ...

As grim as the likely loss of the U.K. market for the drug may be, Lilly is far from helpless, and the damage, while notable, might not actually drag on its growth by a noticeable amount if its ...

U.K. regulators will reportedly recommend that the National Health Service not cover Eli Lilly’s (NYSE:LLY) donanemab for the ...

Its revenue grew from $4.9 billion in 2019 to $9.9 billion in 2023. Per Bloomberg consensus estimates, Chipotle is expected ...

Eli Lilly (LLY) is reportedly preparing to launch Mounjaro in Denmark, the home country of its leading rival in the ...

The historic Zion Baptist Church will receive nearly a quarter of a million dollars to preserve its history and architecture.

The U.K. government issued a new warning aimed at the misuse of GLP-1 therapies by those who don’t qualify for the meds but are instead using them for quick-fix weight loss.

Throwback to when Abhishek Bachchan humorously addressed divorce rumors with Aishwarya Rai, quipping about being informed when he’s remarried.